BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 22343970)

  • 21. Does omentectomy in epithelial ovarian cancer affect survival? An analysis of the Surveillance, Epidemiology, and End Results database.
    McNally L; Teng NN; Kapp DS; Karam A
    Int J Gynecol Cancer; 2015 May; 25(4):607-15. PubMed ID: 25756404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO stage 1a and 1b endometrial adenocarcinoma: treatment implications.
    Aquino-Parsons C; Lim P; Wong F; Mildenberger M
    Gynecol Oncol; 1998 Oct; 71(1):83-6. PubMed ID: 9784324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of patients with uterine serous carcinoma using the revised FIGO staging system.
    Seward S; Ali-Fehmi R; Munkarah AR; Semaan A; Al-Wahab ZR; Elshaikh MA; Cote ML; Morris RT; Bandyopadhyay S
    Int J Gynecol Cancer; 2012 Mar; 22(3):452-6. PubMed ID: 22274544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium.
    Creasman WT; Kohler MF; Odicino F; Maisonneuve P; Boyle P
    Gynecol Oncol; 2004 Dec; 95(3):593-6. PubMed ID: 15581969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women.
    Matthews RP; Hutchinson-Colas J; Maiman M; Fruchter RG; Gates EJ; Gibbon D; Remy JC; Sedlis A
    Gynecol Oncol; 1997 May; 65(2):206-12. PubMed ID: 9159326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term survival in uterine clear cell carcinoma and uterine papillary serous carcinoma.
    Lindahl B; Persson J; Ranstam J; Willén R
    Anticancer Res; 2010 Sep; 30(9):3727-30. PubMed ID: 20944161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation.
    Martinez AA; Weiner S; Podratz K; Armin AR; Stromberg JS; Stanhope R; Sherman A; Schray M; Brabbins DA
    Gynecol Oncol; 2003 Sep; 90(3):537-46. PubMed ID: 13678721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival?
    Garg G; Shah JP; Toy EP; Bryant CS; Kumar S; Morris RT
    Gynecol Oncol; 2010 Jul; 118(1):8-13. PubMed ID: 20447684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and clinical outcomes of non-endometrioid carcinoma of endometrium: Siriraj Hospital experience.
    Jaishuen A; Kunakornporamat K; Viriyapak B; Benjapibal M; Chaopotong P; Petsuksiri J; Therasakvichya S
    Asian Pac J Cancer Prev; 2014; 15(6):2905-9. PubMed ID: 24761923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Restaging and Survival Analysis of 4036 Ovarian Cancer Patients According to the 2013 FIGO Classification for Ovarian, Fallopian Tube, and Primary Peritoneal Cancer.
    Rosendahl M; Høgdall CK; Mosgaard BJ
    Int J Gynecol Cancer; 2016 May; 26(4):680-7. PubMed ID: 26937751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer.
    Matsuo K; Nusbaum DJ; Matsuzaki S; Chang EJ; Roman LD; Wright JD; Harter P; Klar M
    Gynecol Oncol; 2020 Oct; 159(1):43-51. PubMed ID: 32690393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study.
    Sutton G; Axelrod JH; Bundy BN; Roy T; Homesley HD; Malfetano JH; Mychalczak BR; King ME
    Gynecol Oncol; 2005 Jun; 97(3):755-63. PubMed ID: 15913742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina.
    Kosary CL
    Semin Surg Oncol; 1994; 10(1):31-46. PubMed ID: 8115784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.
    Lajer H; Elnegaard S; Christensen RD; Ortoft G; Schledermann DE; Mogensen O
    Acta Obstet Gynecol Scand; 2012 Aug; 91(8):976-82. PubMed ID: 22548255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is adjuvant therapy necessary for stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging?
    Kwon JS; Abrams J; Sugimoto A; Carey MS
    Int J Gynecol Cancer; 2008; 18(4):820-4. PubMed ID: 17892450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved survival with adjuvant brachytherapy in stage IA endometrial cancer of unfavorable histology.
    Shinde A; Li R; Amini A; Chen YJ; Cristea M; Dellinger T; Wang W; Wakabayashi M; Beriwal S; Glaser S
    Gynecol Oncol; 2018 Oct; 151(1):82-90. PubMed ID: 30170976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences.
    Soslow RA; Bissonnette JP; Wilton A; Ferguson SE; Alektiar KM; Duska LR; Oliva E
    Am J Surg Pathol; 2007 Jul; 31(7):979-87. PubMed ID: 17592263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study.
    Garg G; Shah JP; Liu JR; Bryant CS; Kumar S; Munkarah A; Morris RT
    Int J Gynecol Cancer; 2010 Oct; 20(7):1201-6. PubMed ID: 20940535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early-stage Uterine Pure and Mixed Clear Cell Carcinoma: Outcomes and Recurrence With and Without Adjuvant Therapy.
    Chang-Halpenny CN; Natarajan S; Hwang-Graziano JM
    Am J Clin Oncol; 2018 Apr; 41(4):371-378. PubMed ID: 26950465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of adjuvant chemotherapy in surgical stages I-II serous and clear cell carcinomas and carcinosarcoma of the endometrium: a collaborative study.
    Vandenput I; Trovik J; Vergote I; Moerman P; Leunen K; Berteloot P; Neven P; Salvesen H; Amant F
    Int J Gynecol Cancer; 2011 Feb; 21(2):332-6. PubMed ID: 21270614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.